Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Other Operating Expenses (2017 - 2025)

Haemonetics (HAE) has 14 years of Other Operating Expenses data on record, last reported at $11.6 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 4.75% year-over-year to $11.6 million; the TTM value through Dec 2025 reached $33.5 million, down 42.49%, while the annual FY2024 figure was $2.0 million, 423.56% up from the prior year.
  • Other Operating Expenses reached $11.6 million in Q4 2025 per HAE's latest filing, down from $19.8 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $19.8 million in Q3 2025 and bottomed at -$9.3 million in Q1 2025.
  • Average Other Operating Expenses over 5 years is $9.4 million, with a median of $10.5 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: soared 1790.58% in 2023, then crashed 149.54% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $9.6 million in 2021, then plummeted by 96.02% to $382000.0 in 2022, then surged by 1709.16% to $6.9 million in 2023, then skyrocketed by 76.96% to $12.2 million in 2024, then decreased by 4.75% to $11.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $11.6 million in Q4 2025, $19.8 million in Q3 2025, and $11.4 million in Q2 2025.